From MoU to Momentum: Scaling Sweden–US Biotech Trade and Investment

The Tech Prosperity Deal between Sweden and the United States has opened a new chapter for transatlantic collaboration in life sciences, with implications for trade, investment, innovation, and long-term industry partnerships between the two countries.

MSD and AmCham Sweden are delighted to host an exclusive breakfast seminar exploring how this momentum can translate into real growth for the biotech sector. Bringing together leading voices from policy and industry - speakers to be announced - the session will offer perspective on how Sweden and the US can unlock new opportunities for investment, accelerate innovation, and deepen transatlantic life science ties.

Powered by:

(Invitations will be Distributed to AmCham Members Shortly)